ONYX PHARMACEUTICALS INC Net Income
ONYX PHARMACEUTICALS INC reported Net Income of -$53.17 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2013-08-09
- ONYX PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2013-06-30 was -$53.17M.
- ONYX PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2013-03-31 was -$33.67M.
- ONYX PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2012-12-31 was -$42.92M, a 119.81% decline year-over-year.
- ONYX PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2012-09-30 was $17.40M.
- ONYX PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2012 was -$187.79M, a 346.73% decline from fiscal 2011.
- ONYX PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2011 was $76.11M.
- ONYX PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2010 was -$84.85M, a 625.01% decline from fiscal 2009.
- ONYX PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2009 was $16.16M, a 729.62% increase from fiscal 2008.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$53.17M 10-Q · filed 2013-08-09 | -$86.84M 10-Q · filed 2013-08-09 | -$129.76M derived: sum of 3 quarters · filed 2013-08-09 | -$112.36M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | -$33.67M 10-Q · filed 2013-05-08 | -$76.59M derived: sum of 2 quarters · filed 2013-05-08 | -$59.20M derived: sum of 3 quarters · filed 2013-05-08 | -$165.25M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | -$42.92M 10-K · filed 2013-02-28 | -$25.53M derived: sum of 2 quarters · filed 2013-02-28 | -$131.57M derived: sum of 3 quarters · filed 2013-08-09 | -$187.79M 10-K · filed 2013-02-28 |
| 2012-09-30 | $17.40M 10-K · filed 2013-02-28 | -$88.65M derived: sum of 2 quarters · filed 2013-08-09 | -$144.87M 10-Q · filed 2012-11-02 | $71.81M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | -$106.05M 10-Q · filed 2013-08-09 | -$162.26M 10-Q · filed 2013-08-09 | $54.41M derived: sum of 3 quarters · filed 2013-08-09 | $17.55M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | -$56.21M 10-Q · filed 2013-05-08 | $160.46M derived: sum of 2 quarters · filed 2013-05-08 | $123.60M derived: sum of 3 quarters · filed 2013-05-08 | $69.06M derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | $216.68M 10-K · filed 2013-02-28 | $179.81M derived: sum of 2 quarters · filed 2013-02-28 | $125.27M derived: sum of 3 quarters · filed 2013-02-28 | $76.11M 10-K · filed 2013-02-28 |
| 2011-09-30 | -$36.86M 10-K · filed 2013-02-28 | -$91.40M derived: sum of 2 quarters · filed 2013-02-28 | -$140.56M 10-Q · filed 2012-11-02 | -$157.69M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | -$54.54M 10-K · filed 2013-02-28 | -$103.70M 10-Q · filed 2012-08-06 | -$120.83M derived: sum of 3 quarters · filed 2013-02-28 | -$79.33M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | -$49.16M 10-K · filed 2013-02-28 | -$66.28M derived: sum of 2 quarters · filed 2013-02-28 | -$24.78M derived: sum of 3 quarters · filed 2013-02-28 | -$121.97M derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | -$17.12M 10-K · filed 2012-02-27 | $24.38M derived: sum of 2 quarters · filed 2012-02-27 | -$72.80M derived: sum of 3 quarters · filed 2012-02-27 | -$84.85M 10-K · filed 2013-02-28 |
| 2010-09-30 | $41.50M 10-K · filed 2012-02-27 | -$55.68M derived: sum of 2 quarters · filed 2012-02-27 | -$67.73M 10-Q · filed 2011-11-03 | -$73.24M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | -$97.18M 10-K · filed 2012-02-27 | -$109.23M 10-Q · filed 2011-08-09 | -$114.74M derived: sum of 3 quarters · filed 2012-02-27 | -$106.50M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | -$12.04M 10-K · filed 2012-02-27 | -$17.55M derived: sum of 2 quarters · filed 2012-02-27 | -$9.32M derived: sum of 3 quarters · filed 2012-02-27 | $52.00K derived: sum of 4 quarters · filed 2012-02-27 |
| 2009-12-31 | -$5.51M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $2.72M derived: sum of 2 quarters · filed 2012-02-27 | $12.10M derived: sum of 3 quarters · filed 2012-02-27 | $16.16M 10-K · filed 2012-02-27 |
| 2009-09-30 | $8.23M 10-Q · filed 2010-11-03 | $17.61M derived: sum of 2 quarters · filed 2010-11-03 | $21.67M 10-Q · filed 2010-11-03 | |
| 2009-06-30 | $9.37M 10-Q · filed 2010-08-04 | $13.44M 10-Q · filed 2010-08-04 | ||
| 2008-12-31 | $1.95M 10-K · filed 2011-02-23 |